当前位置：   首页 > 需求大厅

 >  特色服务 

 >  信息服务 

1、Ophthalmic viscosurgical devices Article· Literature Review in Current Opinion in Ophthalmology 19(1):50-4 · February 2008 with 82 Reads DOI: 10.1097/ICU.0b013e3282f14db0 · Source: PubMed 2、Lancet Psychiatry. 2019 Mar;6(3):211-224. doi: 10.1016/S2215-0366(18)30511-X. Epub 2019 Feb 18. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Huang Y1, Wang Y2, Wang H3, Liu Z4, Yu X4, Yan J5, Yu Y6, Kou C6, Xu X7, Lu J7… PMID:30792114 3、Prevalence of myopia in local and international schools in Hong Kong. 4、Effects of different concentrations of atropine on controlling myopia in myopic children. 5、Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys 6、Effects of different concentrations of atropine on controlling myopia in myopic children. 7、Use of mechlorethamine gel in patients diagnosed with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL): “Real-world” experience from the Prospective Observational Study (PROVe) 8、Safety and effectiveness of tolvaptan administration after total arch replacement Yasunori Iida, MD, PhD, Akihiro Yoshitake, MD, PhD, Hideyuki Shimizu, MD, PhD 9、The role of tolvaptan administration after cardiac surgery: ameta-analysisIoannis Bellos MD , Dimitrios C. Iliopoulos MD, PhD ,Despina N. Perrea MD, PhD 10、Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: tablets and pellets.Tulain U, Ur-Rahman N.Pak J Pharm Sci. 2008 Apr;21(2):131-8. 11、Relative bioavailability and bioequivalence study of theophylline sustained release formulations. Vergin H, Mahr G, Winterhalter B, Wigand R.Arzneimittelforschung. 2003;53(9):635-9. 12、Use of mechlorethamine gel in patients diagnosed with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL): “Real-world” experience from the Prospective Observational Study (PROVe) 13、journal of medicinal chemistry 2004,47,530 14、Gupta AK, Ryder JE, Lynch LE et al. The use   [更多]

EP10.0药典： 1、Piperacillin Sodium EP10.0 2、替加环素Tigecycline EP10.0 3、阿托品atropine EP10.0 4、硫酸阿托品 EP10.0 5、2.6.31 EP10.0 6、EP10.0: Salmeterol Xinafoate 7、EP10.0: Preparations for inhalation 8、EP10.0: Pressurised pharmaceutical preparations" 9、EP10:ceftazidime 10、Formoterol Fumarate EP10.0 11、乳酸依沙吖啶Ethacridine lactate monohydrate EP10.0 12、Aspartame的EP10.0标准 13、EP10.0 3.1.9 14、perindopril tert-butylamine的EP10.1标准 15、CALCIUM LEVOFOLINATE HYDRATE EP10.0 16、Deslanoside EP10 17、Inhalation powders EP10 18、Fluconazole EP10 19、Nifedipine EP10 20、Calcium Dobesilate Monohydrate 羟苯磺酸钙原料药EP10.0的标准 21、EP10.0 Ipratropium bromide 22、Voriconazole EP10.0 23、Magnesium Stearate硬脂酸镁 EP10.0 24、Colloidal Anhydrous Silica胶态无水二氧化硅 EP10.0 25、Purified water 纯化水 EP10.0 26、Povidone (K-90) 聚维酮 (K-90) EP10.0 27、Hydroxypropyl cellulose (EF)羟丙纤维素 (EF) EP10.0 28、HPMC E-15羟丙甲纤维素E-15 EP10.0 29、Purified Talc 滑石粉 EP10.0 30、Pregelatinised Starch 预胶化淀粉 EP10.0 31、Lactose Monohydrate一水乳糖 EP10.0 32、lsopropyl Alcohol异丙醇 EP10.0 33、Titanium dioxide二氧化钛 EP10.0 34、Polyethylene glycol 400 聚乙二醇400 EP10.0 35、氨丁三醇 TROMETAMOL EP10.0 36、依地酸钙钠 SODIUM CALCIUM EDETATE EP10.0 37、碘帕醇 IOPAMIDOL EP10.0 38、甘露醇 MANNITOL 查EP10.0 39、Macrogol 4000 EP10.0 40、盐酸二甲双胍Metformin hydrochloride，EP10.0 41、Polyoxyl castor oil EP10.0 42、Ascorbic Acid-EP10.0 43、EP10.0中的（5.1.8） 44、EP10.0中的（5.1.4） 45、Carboxymethylcellulose sodium的最新欧洲药典，然后这个monograph（专著）里面有一个取代度的具体方法。 EP10.0 46、Tranexamic Acid EP10.0 47、欧洲药典10.0版Starches hydrocyethyl 48、Dextrose和Glucose monohydrate EP10标准 49、Oxcarbazepine EP10标准 50、Human albumin solution EP10标准 51、Cefoperazone Sodium EP10.0 52、Sulbactam Sodium EP10.0 53、Azithromycin、 EP10标准 54、Aripiprazole EP10.0 55、 Candesartan cilexetil EP10.0 56、Clopidogrel besilate EP10.0 57、Clopidogrel hydrogen sulfate EP10.0 58、Clopidogrel hydrochloride EP10.0 59、Duloxetine hydrochloride EP10.0 60、Galantamine hydrobromide EP10.0 61、Irbesartan EP10.0   [更多]

提供药厂及药品转让项目/合作项目，需要具体的转让信，企业名称，联系方式，信息需真实可靠。   [更多]

求助西地那非原料药信息   [更多]

急需冷敷凝胶、冷敷贴及伤口敷料的一类医疗器械全套备案申请资料   [更多]

文献： 1、" Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature. " Pharmacotherapy 2007;27:290–8. Page RL, Schwiesow J, Hilts A. 2、Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol 2013;39:310–24. Vehreschild JJ, Birtel A, Vehreschild MJGT, et al. 3、Tarantino MD, Fogarty P, Mayer B, Vasey SY, Brainsky A. Efficacy of eltrombopag in management of bleeding symptoms associated with chronic immune thrombocytopenia. Blood Coagul Fibrinolysis. 2013 Apr;24(3):284-96. doi: 10.1097/MBC.0b013e32835fac99. 4、J Med Chem, 51: 4632～4640. Org. Process Res. Dev. 2019, 23, 9, 2057-2068 Pharmazie 73(9):494-497 · September 2018 5、中国医药工业杂志 2012， 43（8）， 644-646 6、精细化工中间体2013，43（2），46-48 7、精细化工中间体2011，41（4），46-48 8、中国现代应用药学2011，28（1），58-59 9、Chemical biology&Drug Design 2014, 83(3), 306-316 10、Letters in organic chemistry 2012, 9(4), 276-279 11、Medicines Evidence Commentary : Chronic kidney disease: calcium-based versus non-calcium-based phosphate binders Source: National Institute for Health and Care Excellence - NICE - 21 January 2014 - Publisher: National Institute for Health and Care Excellence (NICE) 12、double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children 13、J. Med. Chem. 2018, 61, 5304−5322. 14、Chem. Biol. Drug Des. 2014, 83, 306−316. 15、J. Pharm. Biomed. Anal. 2009, 50, 144−150. 16、Int. J. Pharm. Sci. 2016, 8, 97−102. 17、J. Pharm. Biomed. Anal. 2010, 52, 493−507. 18、Org. Process Res. Dev. 2013, 17, 1036−1041. 19、Beilstein J. Org. Chem. 2011, 7, 442− 495. 20、Bioorg. Med. Chem. Lett. 2014, 24, 1108−1110. 21、New Activated PEG Derivatives for Affinity Partitioning 22、Population incidence and mortality of sepsis in an urban African setting 2013-2016 23、Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in   [更多]

需求内容在图片里面   [更多]

中药新药的药学实验室设计图纸，不包括药理毒理、临床，只做药学资料用。（设备清单、SOP、人员建制也可一并提供）根据您提供的内容详细完整和详细程度，可提高报酬。   [更多]

求购British Pharmacopoeia (Veterinary): Chlortetracycline Veterinary Oral Powder《BP2019》的药典标准一份   [更多]

需求名称：阿奇霉素颗粒（0.1g/袋）参比制剂备案的综述资料 具体要求： 1.备案参比制剂为阿奇霉素干混悬剂原研地产化由辉瑞制药有限公司生产，商品名：希舒美，规格：0.1g/包。 2.按照最新法规要求起草综述资料 《参比制剂遴选申请资料》。 3.说明销售数据来源。 4.查询的数据最后有截屏或来源。 5.其他事项再沟通。 要求时间：请在2020年01月10日之前 交稿方式：直接点击交稿在线交稿就是了，我会每天过来看的，谢谢各位药智的战友们   [更多]